Description: Emergent Health Corp. engages in the discovery, development and marketing of products designed to better mankind. Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third party label exemptions. Emergent is focusing current efforts on marketing licensed patent pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their own adult stem cells from their bone marrow. Emergent is also licensed under a patent pending application to market a dual acting all natural diet aid designed to help control hunger through normal body signals to the brain and stomach. Products are being developed for consumer and Professional markets. Research and Development is exploring other areas such as Secretogues that can naturally enhance a person's own Growth Hormone production and similar all natural bioactive formulations to enhance human performance safely, ethically, legally and utilizing known body mechanisms without the use of drugs. Emergent does not claim any of its products diagnose, treat, cure or prevent any disease. Emergent was founded in 2006 and is now headquartered in King of Prussia, PA.
Home Page: www.emergenthealthcorp.com
10120 Valley Forge Circle
King of Prussia,
PA
19406
United States
Phone:
484-518-9000
Officers
| Name | Title |
|---|---|
| Mr. James W. Zimbler | Chief Exec. Officer |
| Mr. Gregory McCauley | Corp. Counsel |
| Mr. Marvin Segel | Director & CMO |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.3393 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |